Dataset Information

PD-L1⁺MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.

ABSTRACT: Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1⁺MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1⁺MDSCs in comparison to those from healthy subjects (p?+MDSCs were reduced by curative treatment for HCC (p?+MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1⁺MDSCs were significantly increased compared with control (p?+MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1⁺MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1⁺MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1⁺MDSCs as a new biomarker of HCC.

SUBMITTER: Iwata T

PROVIDER: S-EPMC5155242 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

PD-L1<sup>+</sup>MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.

Iwata Tomoaki T Kondo Yasuteru Y Kimura Osamu O Morosawa Tatsuki T Fujisaka Yasuyuki Y Umetsu Teruyuki T Kogure Takayuki T Inoue Jun J Nakagome Yu Y Shimosegawa Tooru T

Scientific reports 20161214

Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1<sup>+</sup>MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients co ...[more]

PMID: 27966626

Similar Datasets

Project description:BackgroundPrevious studies have shown clinical relevance of programmed death-ligand 1 (PD-L1) and soluble PD-L1 (sPD-L1) in human cancers. However, still contradictory results exist. Our aim was evaluation of PD-L1-expressing monocytic myeloid-derived suppressor cells (M-MDSCs), monocytes/macrophages (MO/MA), tumour cells (TC) and immune/inflammatory cells (IC) as well as investigation of the sPD-L1 in ovarian cancer (OC) patients.MethodsThe group of 74 pretreatment women were enrollment to the study. The expression of PD-L1 on M-MDSCS and MO/MA was assessed by flow cytometry. The profile of sPD-L1 was examined with ELISA. The expression of PD-L1 in mononuclear cells (MCs) was analyzed using real time PCR. PD-L1 immunohistochemical analysis was prepared on TC and IC. An in silico validation of prognostic significance of PD-L1 mRNA expression was performed based microarray datasets.ResultsOC patients had significantly higher frequency of MO/MA versus M-MDSC in the blood, ascites and tumour (each p?<?0.0001). In contrast, PD-L1 expression was higher on M-MDSCs versus MO/MA in the blood and ascites (each p?<?0.0001), but not in the tumour (p?>?0.05). Significantly higher accumulation of blood-circulating M-MDSC, MO/MA, PD-L1+M-MDSC, PD-L1+MO/MA and sPD-L1 was observed in patients versus control (p?<?0.001, p?<?0.05, p?<?0.001, p?<?0.001 and p?<?0.0001, respectively). Accumulation of these factors was clinicopathologic-independent (p?>?0.05). The expression of PD-L1 was significantly higher on IC versus TC (p?<?0.0001) and was clinicopathologic-independent (p?>?0.05) except higher level of PD-L1+TC in the endometrioid versus mucinous tumours. Interestingly, blood-circulating sPD-L1 positively correlated with PD-L1+M-MDSCs (p?=?0.03) and PD-L1+MO/MA (p?=?0.02) in the blood but not with these cells in the ascites and tumours nor with PD-L1+TC/IC (each p?>?0.05). PD-L1 and sPD-L1 were not predictors of overall survival (OS; each p?>?0.05). Further validation revealed no association between PD-L1 mRNA expression and OS in large independent OC patient cohort (n?=?655, p?>?0.05).ConclusionsAlthough PD-L1 may not be a prognostic factor for OC, our study demonstrated impaired immunity manifested by up-regulation of PD-L1/sPD-L1. Furthermore, there was a positive association between PD-L1+ myeloid cells and sPD-L1 in the blood, suggesting that sPD-L1 may be a noninvasive surrogate marker for PD-L1+myeloid cells immunomonitoring in OC. Overall, these data should be under consideration during future clinical studies/trials.

Project description:BACKGROUND:PD-L1 is an immune inhibitory receptor ligand that leads to T cell dysfunction and apoptosis by binding to its receptor PD-1, which works in braking inflammatory response and conspiring tumor immune evasion. However, in gliomas, the cause of PD-L1 expression in the tumor microenvironment is not yet clear. Besides, auxiliary biomarkers are urgently needed for screening possible responsive glioma patients for anti-PD-1/PD-L1 therapies. METHODS:The distribution of tumor-infiltrating T cells and PD-L1 expression was analyzed via immunofluorescence in orthotopic murine glioma model. The expression of PD-L1 in immune cell populations was detected by flow cytometry. Data excavated from TCGA LGG/GBM datasets and the Ivy Glioblastoma Atlas Project was used for in silico analysis of the correlation among genes and survival. RESULTS:The distribution of tumor-infiltrating T cells and PD-L1 expression, which parallels in murine orthotopic glioma model and human glioma microdissections, was interrelated. The IFN-? level was positively correlated with PD-L1 expression in murine glioma. Further, IFN-? induces PD-L1 expression on primary cultured microglia, bone marrow-derived macrophages, and GL261 glioma cells in vitro. Seven IFN-?-induced genes, namely GBP5, ICAM1, CAMK2D, IRF1, SOCS3, CD44, and CCL2, were selected to calculate as substitute indicator for IFN-? level. By combining the relative expression of the listed IFN-?-induced genes, IFN-? score was positively correlated with PD-L1 expression in different anatomic structures of human glioma and in glioma of different malignancies. CONCLUSION:Our study identified the distribution of tumor-infiltrating T cells and PD-L1 expression in murine glioma model and human glioma samples. And we found that IFN-? is an important cause of PD-L1 expression in the glioma microenvironment. Further, we proposed IFN-? score aggregated from the expressions of the listed IFN-?-induced genes as a complementary prognostic indicator for anti-PD-1/PD-L1 therapy.

Dataset Information

PD-L1⁺MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.

Publications

PD-L1<sup>+</sup>MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Dataset Information

PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.

Publications

PD-L1<sup>+</sup>MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

PD-L1⁺MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.